Your browser doesn't support javascript.
loading
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review.
Rossi, Lorenzo; McCartney, Amelia; De Santo, Irene; Risi, Emanuela; Moretti, Erica; Malorni, Luca; Biganzoli, Laura; Di Leo, Angelo.
Afiliação
  • Rossi L; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy; Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland; Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland.
  • McCartney A; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • De Santo I; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Risi E; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Moretti E; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Malorni L; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Biganzoli L; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Di Leo A; "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy. Electronic address: angelo.dileo@uslcentro.toscana.it.
Cancer Treat Rev ; 74: 29-34, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30708267

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article